Gene Query: CCBE1

Dataset Description Geneva Score
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 156.75
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 118.31
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 109.29
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 109.29
CD95/Fas ligand mRNA is toxic to cells 105.25
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 103.51
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 89.75
Differential gene expression in Jagged1 treated human dental pulp cells. 71.47
Generation of trichogenic adipose-derived stem cells by expression of three factors 56.68
Regulation of Lipids is Central to Replicative Senescence 56.15
RNA expression following TMPRSS11B overexpression or depletion 55.35
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 55.08
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 52.29
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 49.47
RNA-seq of young and quiescent MRC-5 human fibroblasts 47.29
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 47.15
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 46.71
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 46.33
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 46.33
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 44.71
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 44.19
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 41.47
The effect of PPARG inhibition on human angiomyolipoma cells 40.95
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 40.74
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 40.1
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 40.07
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 40.06
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 38.81
RNA-seq of human aneuploid cell lines with Trisomy 21 38.38
TGF-β promotes genomic instability after loss of RUNX3 37.55
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 37.3
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 37.02
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 36.77
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 36.24
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 35.16
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 35.02
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 34.94
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 34.28
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 33.65
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 33.65
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 32.89
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 32.6
Differential analysis of gene regulation at transcript resolution by RNA-Seq 32.6
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 31.55
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 31.52
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 31.52
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 31.52
circRNA-sequencing 30.7
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 30.11
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 30.01
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 30.01
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 28.79
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 28.55
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 28.34
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 28.34
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 27.95
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 27.77
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 26.63
hTERT promotes cell adhesion and migration independent of telomerase activity 25.88
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 25.68
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 25.4
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 25.4
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 25.23
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 24.74
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 24.62
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 24.22
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 23.98
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 23.85
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 23.58
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 23.34
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 22.27
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 22.16
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 22.04
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 21.96
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 21.83
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 21.71
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 21.11
GATA3-mediated chromatin reprogramming in breast cancer cells 20.94
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 20.92
Generation of KRAS signatures using immortalized isogenic lung cells. 20.08
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 19.71
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 19.71
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 19.5
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 19.41
Global expression profiles in cardiac progenitor cells generated by ISX-9 19.05
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 19.05
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 18.92
The interplay between SOX4 and SMAD3 in the context of breast cancer 18.92
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 18.71
Neurofibroma 18.71
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 18.6
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 18.59
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 18.57
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 18.51
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 18.28
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 18.25
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 18.08
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 17.79
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 17.74
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 17.53
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 17.5
Downregulation of LATS kinases alters p53 to promote cell migration 17.47
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 17.46
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 17.43
Expression profiling of etoposide-induced senescent cells 17.17
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 17.12
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 16.51
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 16.51
A role for ZNF598 in post-transcriptional gene regulation 16.5
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 16.24
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 16.24
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 16.14
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  16.07
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 16.01
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 15.96
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 15.96
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 15.75
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 15.75
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 15.73
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 15.73
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 15.64
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 15.64
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 15.64
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 15.56
Investigation about fibroblasts of different origins in culture 15.52
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 15.4
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 15.3
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 15.3
RNA-seq of shEZH2 cells 14.9
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 14.87
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 14.87
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 14.75
Metabolism as an early predictor of DPSCs aging 14.67
High-efficiency RNA-based reprogramming of human primary fibroblasts 14.63
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 14.58
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 14.5
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 14.5
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 14.46
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 14.43
Random mono-allelic expression in MECP2-mutated cells 14.34
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 14.3
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 14.13
Functional role of SLIT2 and ROBO1 in trophoblasts 14.1
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 13.6
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 13.6
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 13.56
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 13.51
Maturation of human iNSCs 13.46
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 13.46
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 13.46
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 13.42
Zika virus infection reprograms global transcription of host cells to allow sustained infection 13.37
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 13.32
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 13.31
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 13.27
Global epigenomic reconfiguration during mammalian brain development 13.23
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 13.19
Inhibition of TNBC metastasis by Gpx1 13.15
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 13.15
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 13.14
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 13.12
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 13.1
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 13.01
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 12.81
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 12.77
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 12.77
Real-time observation of light-controlled transcription in living cells 12.74
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 12.64
HBEC-shp53-PCHD7 12.63
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 12.59
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 12.58
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 12.58
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 12.57
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 12.57
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 12.53
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 12.53
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 12.45
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 12.45
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 12.44
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 12.44
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 12.4
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 12.32
Gene expression analysis of immortalized human liver progenitor-like cells in culture 12.27
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 12.25
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 12.22
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 12.19
Transcriptome analysis of kidney organoids 12.14
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 12.04
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 12.03
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 12.03
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 11.93
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 11.91
Chromatin landscape of human visceral and subcutaneous adipocytes 11.79
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 11.72
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 11.62
Molecular Mechanisms of Endothelial Hyperpermeability 11.56
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 11.52
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 11.46
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 11.39
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 11.39
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 11.29
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 11.23
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 11.18
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 11.13
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 11.08
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 11.08
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 11.03
Determination of tRNA aminoacylation levels by high throughput sequencing 10.93
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 10.85
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 10.84
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 10.8
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 10.71
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 10.69
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 10.56
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 10.54
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 10.53
Genome wide miR-191 target profile determined by RIP and gene expression profiling 10.44
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 10.44
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 10.37
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 10.22
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 10.22
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 10.17
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 10.15
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 10.15
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 10.14
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 9.93
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 9.93
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 9.89
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  9.88
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 9.8
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 9.63
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 9.62
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 9.51
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 9.51
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 9.4
Toxoplasma gondii infection of human retinal pigment epithelial cells 9.35
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 9.13
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 9.12
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 9.12
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 9.07
Lipid degradation promotes prostate cancer cell survival 9.04
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 9.0
iPSC-Derived Cholangiocytes 8.98
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 8.91
Small-molecule targeting of brachyury transcription factor addiction in chordoma 8.9
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 8.9
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 8.9
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 8.85
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 8.84
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 8.84
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 8.8
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 8.79
Next Generation Sequencing of human SMA and healthy control Motor Neurons 8.77
Transcriptome profiling of Normal and Cancerous Prostate Cells 8.75
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 8.72
MicroRNA targetome analysis during HCMV infection 8.65
Spliceosomal disruption of the non-canonical BAF complex in cancer 8.63
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 8.58
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 8.55
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 8.55
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 8.48
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 8.45
Transcriptomic profile of human embryonic renal corpuscles 8.41
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 8.29
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 8.29
IRF1 regulates IFN dependent and independent gene expression 8.22
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 8.21
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 8.18
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 8.17
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 8.17
Redifferentiation of expanded human islet β cells by inhibition of ARX 8.13
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 8.1
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  8.07
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 8.07
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 8.07
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 8.01
CHD1 regulates cell fate determination by activation of differentiation-induced genes 8.0
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 7.93
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 7.91
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 7.86
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 7.82
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 7.76
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 7.72
RNA-Seq from early time points in the kidney differentiation protocol 7.53
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 7.51
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 7.51
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 7.44
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 7.4
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 7.36
CSL RNA-Seq on HKC and SCC cell lines 7.33
CSL 7.33
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 7.32
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 7.22
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 7.22
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 7.21
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 7.18
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 7.11
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 7.11
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 7.06
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 6.96
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 6.96
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 6.88
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 6.71
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 6.71
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 6.68
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 6.65
Genome-wide transcriptional response to random aneuploidy in human cells 6.63
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 6.62
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 6.62
Transcriptome profiling of 5 human adenocarcinoma cell lines 6.6
Fibroblasts in cholesteatoma activate osteoclasts. 6.58
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 6.57
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 6.57
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 6.55
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 6.53
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 6.53
RNA-seq of cells with TET1 knockout 6.52
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 6.46
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 6.33
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 6.31
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 6.31
Expression profiles of the four human major ectodermal lineages 6.24
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 6.2
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 6.2
The MEF2B Regulatory Network - RNA-seq data 6.18
The MEF2B Regulatory Network 6.18
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 6.15
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 6.14
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 6.06
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 5.98
RNA-sequencing of healthy human skeletal myocytes 5.95
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 5.86
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 5.86
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 5.83
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 5.78
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 5.78
A single-cell transcriptome atlas of the human pancreas 5.76
Epigenome regulation during epidermal lineage commitment [RNA-seq] 5.73
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 5.7
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 5.69
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 5.69
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 5.68
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 5.64
RNA-Seq of Breast and Ovarian Cancer Cell Lines 5.58
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 5.56
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 5.52
UV_24h_GRO-Seq 5.51
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 5.47
Global transcriptome analysis of HAP1 cells 5.44
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 5.36
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 5.35
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 5.35
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 5.34
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 5.33
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 5.25
Transcriptional dependencies in diffuse intrinsic pontine glioma 5.21
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 5.18
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 5.15
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 5.13
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 5.13
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 5.1
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 5.08
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 5.0
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 4.92
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 4.86
AUF-1 affected genes in human skin cells 4.78
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 4.65
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 4.62
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 4.59
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 4.56
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 4.52
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 4.52
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 4.49
Nonpregnant and term pregnant human myometrial tissues 4.49
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 4.38
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 4.38
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 4.36
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 4.26
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 4.24
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 4.17
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 4.07
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 4.06
6mer seed toxicity in tumour suppressive microRNAs 3.93
Gene expression profile of CRC-derived HILEC 3.89
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 3.84
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 3.78
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 3.75
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 3.74
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 3.7
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 3.6
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 3.6
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 3.56
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 3.53
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 3.53
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 3.37
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 3.36
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 3.36
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 3.27
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 3.26
Evaluating pre-clinical models for studying NASH driven HCC. 3.25
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 3.25
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 3.25
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 3.25
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 3.24
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 3.15
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 3.12
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 3.11
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 3.07
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 3.03
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 2.99
High-throughput sequencing of PROMPT-enriched samples. 2.99
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 2.93
A549 cell transcriptome responses to infection with H7N9 influenza virus 2.93
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 2.89
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 2.89
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 2.84
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 2.77
RNA-sequencing in immortalized human mammary epithelial cells 2.77
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 2.77
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 2.74
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 2.69
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 2.69
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 2.69
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 2.65
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 2.63
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 2.62
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 2.61
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 2.46
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 2.42
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.35
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 2.34
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 2.34
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 2.26
mRNA sequencing of oropharyngeal cancer cell lines 2.25
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 2.23
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 2.2
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.18
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 2.13
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.13
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.13
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 2.08
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 2.04
Activity-dependent transcriptional changes in human neurons 1.95
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.91
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 1.87
6mer seed toxicity in viral microRNAs 1.83
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 1.8
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.58
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.58
RNA-Seq with and without RNase treatment in PCa cell lines 1.51
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 1.43
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 1.41
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 1.39
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 1.33
mRNA differential expression analysis in a human ex vivo model of chronic wounds 1.25
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 1.25
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 1.23
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 1.22
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 1.22
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 1.14
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 1.11
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 1.07
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 1.02
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.98
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.97
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.94
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.9
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.88
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.85
Identification of differentially expressed genes between senescence and senescence bypass cells 0.78
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 0.75
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.75
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.74
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.74
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.72
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.66
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 0.64
Gene expression of thyroid cancer cell lines 0.58
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 0.57
RNA-seq of cancer cell lines treated with T-025 0.55
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 0.51
Positively selected enhancer elements endow tumor cells with metastatic competence 0.46
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.46
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 0.44
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 0.39
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.32
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 0.27
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 0.26
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 0.23
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 0.23
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.17
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.17
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.16
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.13
hNSCs siRNA NOVA2 0.11
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 0.1
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 0.1
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.05
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.05
BMS-470539 on human synovial fibroblasts 0.04


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation